CD8A and neoplasm: Collectively, these findings demonstrate that the Ttex/CD8+ ratio is a tumor-context-specific biomarker whose prognostic interpretation depends on mutational burden, stromal architecture, and the presence of supportive progenitor Tpex pools (131).